Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Video
  4. /
  5. Lissencephaly

Lissencephaly

December 18, 2012[email protected]

Lissencephaly

News

  • Alyftrek Shows Safety and Improved CFTR Function in Children With Cyst
  • Argenx to Present New VYVGART Data in Myasthenia Gravis and CIDP at 20
  • UniQure Reports Sustained 48-Month Slowing of Huntington’s Disease P
  • Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratri
  • Mirum Pharmaceuticals and Incyte Announce FDA Approval of ATEBRIOZ™
More News

Access Programs

  • Jonsson Comprehensive Cancer Center – Progressive Metastatic Cas
  • Massachusetts General Hospital – Healthy Naturally Cycling Women
  • Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal
  • Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell L
  • Kite, A Gilead Company – Relapsed/Refractory Transformed Follicu
More Access Programs
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2026 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo